Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Regulating certain sex hormones may help delay facial aging.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Some supplements and hormones can increase hair loss by raising DHT levels.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Losing weight and taking birth control pills can greatly improve severe male hormone excess in women with PCOS.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.